In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Probes Inc.

http://www.bostonprobes.com

Latest From Boston Probes Inc.

The Next Best Thing in Diagnostics?

Analysts expect the market for DNA probes to grow a hefty 20% a year from now through 2006, but presently the segment is still a relatively small part of the $18-$20 billion diagnostics products industry. Worldwide sales of DNA probes now total $600 million or so, which tells Jack Johansen, PhD, CEO of Boston Probes Inc. that other new probe-based technologies stand a good chance of gaining acceptance.

Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
UsernamePublicRestriction

Register